Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 6Tumor-Agnostic 3Gastrointestinal 3Thoracic 2Genitourinary 2Sarcoma 1Other solid neoplasm 1Lymphoid 1CNS 1

Conditions

Urologic Neoplasms 1Prostatic Neoplasms 1

Interventions

Docetaxel 390pembrolizumab 326Prednisone 285Gemcitabine 273enzalutamide 256Radiotherapy 251Nivolumab 248Magnetic Resonance Spectroscopy 247Cisplatin 209Abiraterone Acetate 198Radiosurgery 184Leuprolide 182Sunitinib 169Carboplatin 161bicalutamide 148Goserelin 145Androgen Antagonists 142Specimen Handling 138Ipilimumab 128Paclitaxel 125Cyclophosphamide 116acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 110Bevacizumab 109Everolimus 107apalutamide 99abiraterone 99cabozantinib 98atezolizumab 97Sorafenib 97Radiation 89

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Meditation × Genitourinary × Clear all
NCT03507725 2024-10-16

Early Staged Consent Before Prostate Biopsy

Memorial Sloan Kettering Cancer Center

Phase NA Completed
390 enrolled
Genitourinary

Prostatic Neoplasms

NCT05072639 2021-10-22

Preoperative Guided Imagery in Patients Undergoing Urologic Surgery

University of California, San Francisco

Phase NA Completed
123 enrolled
Genitourinary

Urologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡